1. Home
  2. ORGO

ORGO

Organogenesis Holdings Inc.

Logo Organogenesis Holdings Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Founded: 1985 Country:
United States
United States
Employees: N/A City: CANTON
Market Cap: 380.1M IPO Year: N/A
Target Price: $4.83 AVG Volume (30 days): 743.0K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.04 EPS Growth: -66.67
52 Week Low/High: $1.79 - $4.71 Next Earning Date: 05-09-2024
Revenue: $433,140,000 Revenue Growth: -3.94%
Revenue Growth (this year): 7.08% Revenue Growth (next year): 7.85%

Share on Social Networks: